Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 30;11(1):187.
doi: 10.3390/jcm11010187.

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology

Affiliations
Editorial

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology

Nikoleta Bizymi et al. J Clin Med. .

Abstract

Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with immunomodulating properties, mainly acting by suppressing T-cell responses [...].

PubMed Disclaimer

Conflict of interest statement

H.A.P. served as the Guest Editor of the Special Issue “Myeloid-Derived Suppressor Cells (MDSCs) in Haematology”. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Similar articles

Cited by

References

    1. Gabrilovich D.I. MDSCs. Cancer Immunol. Res. 2018;5:3–8. doi: 10.1158/2326-6066.CIR-16-0297. - DOI - PMC - PubMed
    1. Vanhaver C., van der Bruggen P., Bruger A.M. MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer. J. Clin. Med. 2021;10:2872. doi: 10.3390/jcm10132872. - DOI - PMC - PubMed
    1. Bizymi N., Bjelica S., Kittang A.O., Mojsilovic S., Velegraki M., Pontikoglou C., Roussel M., Ersvær E., Santibañez J.F., Lipoldová M., et al. Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets. HemaSphere. 2019;3:e168. doi: 10.1097/HS9.0000000000000168. - DOI - PMC - PubMed
    1. Kapor S., Santibanez J.F. Myeloid-Derived Suppressor Cells and Mesenchymal Stem/Stromal Cells in Myeloid Malignancies. J. Clin. Med. 2021;10:2788. doi: 10.3390/jcm10132788. - DOI - PMC - PubMed
    1. Papafragkos I., Markaki E., Kalpadakis C., Verginis P. Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies. J. Clin. Med. 2021;10:3462. doi: 10.3390/jcm10163462. - DOI - PMC - PubMed

Publication types

LinkOut - more resources